FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

1230117002: Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Jun 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
5067242010 Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
5067243017 Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form en Synonym Active Entire term case insensitive SNOMED CT core module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Is a Product containing only bacitracin and neomycin and sulfacetamide (medicinal product) true Inferred relationship Existential restriction modifier
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Is a Product containing bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Has active ingredient Sulfacetamide true Inferred relationship Existential restriction modifier 1
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Has active ingredient Neomycin true Inferred relationship Existential restriction modifier 2
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Has active ingredient Bacitracin true Inferred relationship Existential restriction modifier 3
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Has manufactured dose form Cutaneous dose form true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug) Is a True Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start